05:11 PM EST, 03/05/2024 (MT Newswires) -- Jason P Rhodes, Director, on March 01, 2024, sold 46,534 shares in Dyne Therapeutics ( DYN ) for $1,398,347. Following the Form 4 filing with the SEC, Rhodes has control over a total of 6,545,479 shares of the company, with 6,545,479 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000141588924006766/xslF345X03/form4-03052024_100311.xml